Lanjun Xu

463 total citations
9 papers, 366 citations indexed

About

Lanjun Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lanjun Xu has authored 9 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Lanjun Xu's work include Sarcoma Diagnosis and Treatment (2 papers), DNA Repair Mechanisms (2 papers) and Autophagy in Disease and Therapy (2 papers). Lanjun Xu is often cited by papers focused on Sarcoma Diagnosis and Treatment (2 papers), DNA Repair Mechanisms (2 papers) and Autophagy in Disease and Therapy (2 papers). Lanjun Xu collaborates with scholars based in China, United States and Netherlands. Lanjun Xu's co-authors include Dalong Ma, Yingyu Chen, Dong Xu, Ying Wang, Quansheng Song, Xingwei Wang, Lin Miao, Du Feng, Quan Chen and Tibor Kovács and has published in prestigious journals such as The Journal of Cell Biology, Archives of Biochemistry and Biophysics and EMBO Molecular Medicine.

In The Last Decade

Lanjun Xu

9 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanjun Xu China 7 249 103 68 60 56 9 366
Junying Jia China 10 170 0.7× 86 0.8× 97 1.4× 25 0.4× 78 1.4× 10 395
Nicole Arbour Canada 4 348 1.4× 117 1.1× 110 1.6× 18 0.3× 50 0.9× 6 456
Orie Nakamura Japan 12 122 0.5× 24 0.2× 29 0.4× 45 0.8× 61 1.1× 20 375
Tatsuyuki Matsudaira Japan 8 266 1.1× 51 0.5× 27 0.4× 57 0.9× 105 1.9× 10 463
Thore Schmedt United States 12 274 1.1× 41 0.4× 26 0.4× 11 0.2× 31 0.6× 15 742
Ting Peng China 13 173 0.7× 59 0.6× 44 0.6× 16 0.3× 48 0.9× 29 335
Gwendolyn S. Adrian United States 10 247 1.0× 38 0.4× 33 0.5× 11 0.2× 24 0.4× 13 374
Yapeng Gu United States 6 155 0.6× 23 0.2× 49 0.7× 19 0.3× 181 3.2× 6 350
Jozef P. Bossowski France 7 222 0.9× 181 1.8× 28 0.4× 7 0.1× 80 1.4× 9 363

Countries citing papers authored by Lanjun Xu

Since Specialization
Citations

This map shows the geographic impact of Lanjun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanjun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanjun Xu more than expected).

Fields of papers citing papers by Lanjun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanjun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanjun Xu. The network helps show where Lanjun Xu may publish in the future.

Co-authorship network of co-authors of Lanjun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lanjun Xu. A scholar is included among the top collaborators of Lanjun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanjun Xu. Lanjun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhao, Hongyu, Yan Zhao, Xingwei Wang, et al.. (2013). Mice deficient in Epg5 exhibit selective neuronal vulnerability to degeneration. The Journal of Cell Biology. 200(6). 731–741. 98 indexed citations
2.
Xu, Lanjun, Jing Hu, Yuanbo Zhao, et al.. (2012). PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway. APOPTOSIS. 17(11). 1235–1245. 60 indexed citations
3.
Siudeja, Katarzyna, Balaji Srinivasan, Lanjun Xu, et al.. (2011). Impaired Coenzyme A metabolism affects histone and tubulin acetylation in Drosophila and human cell models of pantothenate kinase associated neurodegeneration. EMBO Molecular Medicine. 3(12). 755–766. 66 indexed citations
4.
Huang, Jing, Li Zhang, Lin Xiao, et al.. (2011). The role of human ADA2a in the regulation of p53 acetylation and stability. Chinese Science Bulletin. 56(4-5). 397–405. 2 indexed citations
5.
Chen, Changbao, Hua Zhou, Lanjun Xu, et al.. (2010). Prognostic significance of downregulated expression of programmed cell death 5 in chondrosarcoma. Journal of Surgical Oncology. 102(7). 838–843. 23 indexed citations
6.
Chen, Changbao, Hua Zhou, Lanjun Xu, et al.. (2010). Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo. APOPTOSIS. 15(7). 805–813. 39 indexed citations
7.
Xu, Lanjun, Yingyu Chen, Quansheng Song, et al.. (2009). PDCD5 Interacts with Tip60 and Functions as a Cooperator in Acetyltransferase Activity and DNA Damage-Induced Apoptosis. Neoplasia. 11(4). 345–IN2. 67 indexed citations
8.
Yao, Hongwei, Lanjun Xu, Yingang Feng, et al.. (2009). Structure–function correlation of human programmed cell death 5 protein. Archives of Biochemistry and Biophysics. 486(2). 141–149. 10 indexed citations
9.
Xu, Lanjun, et al.. (2006). [Preparation and identification of monoclonal antibodies against human programmed cell death 10 (PDCD10)].. PubMed. 38(6). 586–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026